Filing Details

Accession Number:
0000315066-22-001406
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-11 10:40:00
Reporting Period:
2022-02-09
Accepted Time:
2022-02-11 10:40:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840574 Verve Therapeutics Inc. VERV () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 245 Summer Street
Boston MA 02210
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-02-09 13,190 $29.46 829,694 No 4 S Indirect F-Prime Capital Partners Healthcare Fund V LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect F-Prime Capital Partners Healthcare Fund V LP
Footnotes
  1. The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $29.25 to $29.78. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.